Our intelligent solutions help healthcare providers and their patients optimize drug regimens along the entire care journey, from prescribing through adherence, for a safer, more effective, and efficient path to successful medication therapy.
Request a demo
Medication errors are a major public health issue. Medication success can help combat them.
Americans goes to a hospital emergency department due to an adverse drug event. (CDC)
individuals are seen in hospital emergency departments for adverse drug events every year in the United States (CDC).
the predicted number of hospitalizations of older Americans over the next ten years (LOWN Institute, 2019).
the risk of an adverse drug event increases by 7–10% with each medication (LOWN Institute, 2019).
A suite of pre-built plug ‘n play prescription assistance APIs and components to quickly and easily improve prescribing for your healthcare professionals and provide safer, more accurate patient care.
Learn more
The care journey for chronic conditions such as cancer can be complex for both patients and their care providers. Explore Synapse Platform’s medication success solution for improved patient outcomes.
Learn more
Discover how Synapse Platform automates the detection of medication errors, supports treatment adherence and improves team collaboration.
Mesdocteurs is a telehealth solution that uses Synapse Platform and its prescription assistance modules. Our prescribers particularly appreciate this solution, because it allows them to ensure the safety of their prescriptions.
Synapse Medicine’s Medication Shield is an AI-powered solution for pharmacovigilance that facilitates the management of adverse event reports. Winner of the 2021 Prix Galien.
![[object Object]](https://images.prismic.io/synapse-website/963162bb-86fd-48bc-910c-3af4572af186_cle%CC%81ment-goehrs-te%CC%81moignage-covid19.png?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&rect=0%2C0%2C60%2C60&w=48&h=48)
Co-founder and CEO of Synapse Medicine
"I am incredibly proud of our team and our various initiatives during this coronavirus pandemic. Each and every one of them has proven beyond any remaining doubt that it is possible for a start-up company to collaborate constructively with public institutions and to have a nationwide impact on everyone’s health."
